Mylan Executive Allegedly Cut Price-Fixing Deals with Competitor

Mylan NV’s second-most senior executive allegedly told one of his generic-drug industry rivals that he would “play fair” and divide up market share for a key antibiotic, according to an unredacted version of a lawsuit accusing more than a dozen drugmakers of price-fixing.

Makers of generic drugs, including many of the biggest companies in the industry, are facing a civil complaint by more than 40 states, the District of Columbia and Puerto Rico that they used dinner parties, trade shows, phone calls and texts to agree to raise or maintain prices for specific drugs in tandem, or delineate each company’s ...